# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-074281
Filing Date
2025-08-11
Accepted
2025-08-11 16:01:07
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0250224-10q_oruka.htm iXBRL | 10-Q | 1312278
2 | CERTIFICATION | ea025022401ex31-1_oruka.htm | EX-31.1 | 11791
3 | CERTIFICATION | ea025022401ex31-2_oruka.htm | EX-31.2 | 11886
4 | CERTIFICATION | ea025022401ex32-1_oruka.htm | EX-32.1 | 7559
| Complete submission text file | 0001213900-25-074281.txt |  | 7134506

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | orka-20250630.xsd | EX-101.SCH | 68087
6 | XBRL CALCULATION FILE | orka-20250630_cal.xml | EX-101.CAL | 32465
7 | XBRL DEFINITION FILE | orka-20250630_def.xml | EX-101.DEF | 334184
8 | XBRL LABEL FILE | orka-20250630_lab.xml | EX-101.LAB | 560947
9 | XBRL PRESENTATION FILE | orka-20250630_pre.xml | EX-101.PRE | 353863
81 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0250224-10q_oruka_htm.xml | XML | 980114

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 251201893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)